Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Streptococcus Pneumoniae, Invasive Disease”

46 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 46 results

Not applicableStudy completedNCT01128439
What this trial is testing

Study Estimating the Impact of Prevnar 13™ (13vPnC) on Invasive Pneumococcal Disease

Who this might be right for
Invasive Pneumococcal Disease
Pfizer 1
Not applicableUnknownNCT03102840
What this trial is testing

Understanding Pneumococcal Carriage and Disease 2017-2020

Who this might be right for
Streptococcus Pneumoniae InfectionStreptococcus Pneumoniae, Invasive DiseaseStreptococcal Pneumonia
University of Oxford 2,400
Large-scale testing (Phase 3)UnknownNCT05934890
What this trial is testing

Evaluate the Immunogenicity and Safety of Walvax's PCV13-TT as Compared to Pfizer's PCV13

Who this might be right for
Pneumococcal Disease, Invasive
Walvax Biotechnology Co., Ltd. 630
Testing effectiveness (Phase 2)Active Not RecruitingNCT06790290
What this trial is testing

Phase 2 Trial to Evaluate Safety and Immunogenicity of Inventprise's (IVT) 25-valent Pneumococcal Conjugate Vaccine (IVT PCV-25) in Healthy Infants

Who this might be right for
Pneumococcal Disease, Invasive
Inventprise Inc. 421
Post-approval studies (Phase 4)Study completedNCT00744263
What this trial is testing

Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults

Who this might be right for
Pneumonia, PneumococcalPneumococcal Infections13-valent Pneumococcal Vaccine
Pfizer 84,496
Early research (Phase 1)Study completedNCT03460730
What this trial is testing

Dynamics of the Immune Response in Children to the 23-valent Pneumococcal Capsular Polysaccharide Vaccine (Pneumovax)

Who this might be right for
Pneumonia, Pneumococcal
KEMRI-Wellcome Trust Collaborative Research Program 100
Early research (Phase 1)Looking for participantsNCT07205289
What this trial is testing

Serum Collection Study for Assay Development

Who this might be right for
Pneumococcal Disease, InvasivePneumococcal Disease
GPN Vaccines 12
Large-scale testing (Phase 3)Study completedNCT00839254
What this trial is testing

Impact on Carriage, Acute Otitis Media, Immuno & Safety of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A

Who this might be right for
Infections, StreptococcalStreptococcus Pneumoniae
GlaxoSmithKline 6,181
Not applicableStudy completedNCT03331952
What this trial is testing

Streptococcus Pneumonia Colonisation and Invasive Disease in Cambodian Children

Who this might be right for
Streptococcal Pneumonia
University of Oxford 4,111
Large-scale testing (Phase 3)Study completedNCT00861380
What this trial is testing

Evaluation of Effectiveness of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A Against Invasive Disease

Who this might be right for
Infections, StreptococcalStreptococcus Pneumoniae
GlaxoSmithKline 41,188
Testing effectiveness (Phase 2)Study completedNCT02274415
What this trial is testing

Immunogenicity Study of an Anti-pneumococcal Vaccination Strategy in Patients With Sickle Cells Disease

Who this might be right for
Invasive Pneumococcal InfectionsSickle Cells Disease
Assistance Publique - Hôpitaux de Paris 116
Large-scale testing (Phase 3)Study completedNCT02447432
What this trial is testing

Compare the Immunogenicity of GSK Biologicals' 10Pn-PD-DiT 4-dose Presentation to the Licensed 1-dose Synflorix™ (10Pn-PD-DiT) Vaccine When Co-administered With DTPw-combination Vaccine in Healthy Infants

Who this might be right for
Infections, Streptococcal
GlaxoSmithKline 320
Not applicableStudy completedNCT01810861
What this trial is testing

Serotype Distribution of Streptococcus Pneumoniae That Causes Invasive Diseases at Children and Adults in Turkey

Who this might be right for
Pneumococcal Diseases
Pfizer 922
Post-approval studies (Phase 4)Study completedNCT03489018
What this trial is testing

The Effect of Fractional Doses of Pneumococcal Conjugate Vaccines on Immunogenicity and Carriage in Kenyan Infants

Who this might be right for
Pneumococcal InfectionStreptococcus Pneumoniae InfectionInvasive Pneumococcal Disease, Protection Against
London School of Hygiene and Tropical Medicine 2,100
Not applicableStudy completedNCT02463539
What this trial is testing

Residual Anti-pneumococcal Immunity After Pneumococcal Immunization in ANCA-associated Vasculitis

Who this might be right for
Pneumococcal InfectionANCA-associated Vasculitis
Assistance Publique - Hôpitaux de Paris 19
Not applicableStudy completedNCT00227188
What this trial is testing

Study Evaluating Prevenar in the Prevention of Invasive Pneumococcal Disease (IPD) in the Paediatric Population in Spain.

Who this might be right for
Invasive Pneumococcal Disease
Pfizer 408
Not applicableStudy completedNCT04464291
What this trial is testing

An Epidemiological Survey to Establish the Spectrum of Circulating Serotypes of S. Pneumoniae, in Patients Older 18 Years

Who this might be right for
Pneumonia, PneumococcalInvasive Pneumococcal DiseaseAcute Otitis Media
The Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC) 500
Post-approval studies (Phase 4)Study completedNCT02034877
What this trial is testing

13-valent Pneumococcal Conjugate Vaccine Study in Adults and Children in India

Who this might be right for
Prevention of Pneumonia and Invasive Disease Caused by the Serotypes in 13vPnC
Pfizer 1,200
Large-scale testing (Phase 3)Study completedNCT00853749
What this trial is testing

Immune Response In Children Revaccinated With Pneumococcal Conjugate Vaccine

Who this might be right for
Invasive Pneumococcal Disease
Wyeth is now a wholly owned subsidiary of Pfizer 89
Testing effectiveness (Phase 2)Study completedNCT01215188
What this trial is testing

Pneumococcal Conjugate Vaccine (V114) Compared to a Marketed Vaccine (V114-003)

Who this might be right for
Pneumococcal Infections
Merck Sharp & Dohme LLC 1,152
Next Page